Company news
Sernova Biotherapeutics Inc (TSX:SVA) news
Sernova Biotherapeutics Inc news releases on 6ix. Latest, Mar 1, 2021: Sernova Announces Closing of C$23 Million Bought Deal Financing Including Full Exercise…
Press releases — page 3
Sernova Announces Closing of C$23 Million Bought Deal Financing Including Full Exercise of Over-Allotment Option
March 1, 2021
Sernova Corp. Selected for the TSX Venture Stock Exchange's 2021 Venture 50 List of Top Performing Listed Companies
February 25, 2021
Sernova Obtains Final Prospectus Receipt for $20 Million Bought Deal
February 24, 2021
Sernova Announces Second Annual Data Safety Monitoring Board Review of its Diabetes Cell Pouch System(tm) Clinical Trial and Recommendation for Protocol Continuation
February 18, 2021
BTV News Alert Video: Sernova Corp. - A Functional Cure for Type I Diabetes
February 5, 2021
Sernova Upsizes Previously Announced Bought Deal Public Offering to C$20 Million
February 4, 2021
Sernova Shares Accepted for Trading on the Electronic Trading Platform Xetra in Germany
February 4, 2021
Sernova Corp. Announces C$10 Million Bought Deal Offering of Units
February 3, 2021
Sernova's Collaborator to Present Cell Pouch(TM) Thyroid Transplant Study Results at the American Association of Endocrine Surgeons 2021 Annual Meeting
February 3, 2021
(RADIO INTERVIEW) Sernova Continues to Draw Media Attention: Global News London Goes In-Depth with Dr. Philip Toleikis
February 2, 2021
Sernova Announces Collaboration Agreements with Multiple Pharmaceutical Industry Leaders
January 28, 2021
Sernova Announces Warrants Exercise for Proceeds of $4.3 Million and Early Conversion of Debenture
January 25, 2021
Sernova CEO to Present Regenerative Medicine Therapeutics Platform Update at the 2021 Cell & Gene Therapy Meeting on the Med
January 21, 2021
Sernova Principal Investigator Presents Additional Positive Preliminary Safety and Efficacy Data from Ongoing U.S. Phase I/II Cell Pouch Clinical Trial for Type-1 Diabetes
January 18, 2021
Sernova to Present at H.C. Wainwright BioConnect 2021 Conference
December 18, 2020
(PODCAST) Sernova's Visibility Increases Ahead of Holidays
December 16, 2020
Sernova Corp. Responds to Market Activity
December 11, 2020
Sernova Medical Advances Gain Media Attention
December 3, 2020
Sernova Announces Clinical Trial Investigator Presentation at the ASTS 21st Winter Symposium
November 30, 2020
Sernova Provides Clinical Update on U.S. Phase I/II Cell Pouch(TM) Trial for Type 1 Diabetes
November 18, 2020
Sernova Announces 3-Month Extension of Warrants
October 30, 2020
(Exclusive) Sernova Presents at TSX Life Sciences Investor Day: Available Now!
October 29, 2020
Sernova to Present at TSX Life Sciences Investor Day
October 27, 2020
Sernova to Present at Virtual BIO Investor Forum
September 24, 2020
Sernova Closes Oversubscribed Private Placement and Accelerates Development Programs
September 23, 2020
Sernova to Participate in Cell and Gene Therapies for Chronic Conditions Panel at the Virtual 2020 Cell & Gene Meeting on the Mesa Conference
September 10, 2020
Sernova Announces Up to $3 Million Private Placement Financing with a Lead Order of $2 Million
September 9, 2020
Sernova Enters into Exclusive Worldwide License Agreement with University of Miami for Therapeutic Cell Immune Protection Technologies
August 4, 2020
Dr. Anke M. Schulte Joins Sernova Global Advisory Board
July 16, 2020
Sernova Highlights Positive Results Presented at the American Diabetes Association's Virtual 80th Scientific Sessions
June 18, 2020
Sernova Completes Acquisition of Cellular Local Immune Protection Technology
June 15, 2020
Sernova to Acquire Cellular Local Immune Protection Technology Accelerating Expansion of its Regenerative Medicine Therapeutics Platform
June 8, 2020
Sernova to Present Clinical Validation of the Cell Pouch as a Viable, Safe Site for Diabetes Cell Therapy at the American Diabetes Association's Virtual 80th Scientific Sessions
June 3, 2020
AgeX Therapeutics and Sernova to Collaborate to Engineer Universal Locally Immune Protected Cell Therapies for Type I Diabetes and Hemophilia A
May 29, 2020
Sernova Announces Change of Location of Annual Meeting of Shareholders
May 26, 2020
Sernova Highlights Achievements of the HemAcure Hemophilia Cell Therapy Program Presented at ASGCT
May 19, 2020
Sernova Announces Presentation of HemAcure Hemophilia Program Results at 23rd Annual Meeting of the American Society of Gene and Cell Therapy
May 12, 2020
Sernova Advances Annual General Meeting and CEO Teleconference to Friday May 29
April 27, 2020
Important COVID-19 Safety Measures for Sernova's 2020 Annual Meeting of Shareholders
April 21, 2020
Sernova Provides Corporate Update and Outlook for 2020
March 24, 2020
Sernova to Present Corporate Update at Noble Capital Markets Investor Conference
February 17, 2020
Sernova Achieves Positive Efficacy Endpoint in Phase I/II Clinical Trial for Type 1 Diabetes
February 13, 2020
Sernova Announces Positive DSMB Review and Recommendation for Continuation of Phase I/II Diabetes Clinical Trial of Cell Pouch(TM)
February 10, 2020
Sernova Announces Biotech Veteran as New Chief Financial Officer
October 24, 2019
InvestmentPitch Media Video Discusses Sernova Corp's Further Validation of Cell Pouch and Therapeutic Cell Performance in Type-1 Diabetes - Video Available on Investmentpitch.com
October 17, 2019
Sernova Confirms Enduring Levels of Fasting C-Peptide in Bloodstream of First Patient in its Phase I/II Clinical Trial for Type-1 Diabetes
October 16, 2019
Sernova Renews Frontier Flex for Canadian Investor Relations and Marketing
September 17, 2019
Sernova Completes Oversubscribed Private Placement of $4,684,564
September 10, 2019
Sernova Announces Second Closing of Private Placement
September 3, 2019
Sernova Announces First Closing of Private Placement
August 19, 2019